# OnCo record idea-cost-biosimilar-default-substitution (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-cost-biosimilar-default-substitution/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-cost-biosimilar-default-substitution" ;
  schema:name "Make the biosimilar the default at the pharmacy for trastuzumab, bevacizumab and rituximab"@en ;
  schema:description "Copies of the big antibody drugs are approved and cheaper, but uptake depends on each prescriber; letting the pharmacy substitute the biosimilar unless the oncologist objects would move most patients within a year."@en ;
  schema:url <https://onco.cc/ideas/idea-cost-biosimilar-default-substitution/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/biosimilars-in-the-united-states-2023-2027>, <https://www.fda.gov/drugs/therapeutic-biologics-applications-bla/biosimilars> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/trastuzumab-biosimilars/>, <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/drugs/rituximab/> ;
  onco:terms <https://onco.cc/terms/biosimilar/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-drug-pricing/>, <https://onco.cc/bottlenecks/b-knowledge-diffusion/> .